Why Revocable Living Trusts Fail to Protect Assets from Nursing Home Expenses
According to a Kiplinger analysis authored by an estate planning and elder law attorney with over three decades of practice, a standard estate planning instrument — the revocable living trust — does…

According to a Kiplinger analysis authored by an estate planning and elder law attorney with over three decades of practice, a standard estate planning instrument — the revocable living trust — does not shield assets from long-term care costs. For skilled nursing operators and the families navigating admission, the distinction between probate protection and creditor protection is operational, not technical. It determines whether a resident enters as a private-pay patient or transitions to Medicaid reimbursement, and at what acuity level.
The probate-versus-creditor gap
A revocable living trust lets a grantor transfer assets into a legal vehicle while retaining full control, including the right to remove any asset at any time. Because those assets are still treated as belonging to the grantor, they remain available to creditors. In long-term care, the largest creditor most households ever face is a nursing home.
This is why an RLT solves the probate problem but not the long-term care financing problem. The Kiplinger analysis notes that many families spend thousands drafting and funding an RLT believing they have addressed both, when they have addressed only one. The gap surfaces at intake, when private-pay rates begin drawing down the very assets the trust was meant to protect. By the time Medicaid eligibility is examined, the reimbursement trajectory is already set.
The Medicaid planning blind spot
The piece argues that most estate planning attorneys do not flag this limitation because they do not practice in Medicaid planning. An irrevocable Medicaid Asset Protection Trust (MAPT) is identified as the alternative, because assets transferred out of the grantor's ownership can, with proper structuring and a look-back period, be sheltered from long-term care costs.
The operational consequence is timing. Families who discover the gap after a diagnosis — Alzheimer's, Parkinson's, or another chronic illness requiring years of home care, assisted living, memory care, and eventually nursing-home placement — face a compressed planning window. Options narrow precisely when acuity levels and care hours are escalating, and when the five-year look-back review becomes the binding constraint.
What operators and families should track
For facility operators, the practical signal sits on the intake side. Private-pay-to-Medicaid conversion is a revenue-cycle event shaped by what a family structured — or failed to structure — years before admission. Reimbursement thresholds, payer-mix shifts, and acuity transitions are pre-determined by legal documents that have nothing to do with clinical assessment. Deficiency exposure rarely comes from this, but margin compression does.
For families, the bottom line is direct: probate avoidance and long-term care cost protection are two separate planning problems. Confirm that any estate plan addresses the second one, with an attorney who practices Medicaid planning — not only estate settlement. A trust that works at death may leave nothing to distribute, because the nursing home got there first.